Tel Aviv-based TopGum Industries has established a subsidiary in New Jersey. The company recruited two dietary supplement industry veterans to head business development for the venture and bring TopGum to the US market.
Christopher Lamb will join the subsidiary as VP of Sales and will lead its go-to-market activities. Lamb has experience in business development and sales leadership in the nutritional food, pharma, and supplement space.
Jennifer Toomey joins as the Director of New Product Development and will head the R&D force in the US. She brings 20 years of experience in dietary supplement product development leveraging her training in nutrition.
“The US is a strategic market for us, as it has a well-established gummy supplement market that is open to innovation and expansion,” said Amichai Bar-Nir, TopGum CEO. “We are happy to expand the TopGum family with top industry leaders who bring an in-depth knowledge of this sector and a genuine appreciation for the added value TopGum brings to the market. This US subsidiary demonstrates TopGum’s ongoing commitment to provide our strategic partners unsurpassed service.
According to Innova Market Insights, gummy supplement launches increased by 33% average annual growth in the US from 2015 through 2019. The top health positionings in the US are: immune health, skin health, bone health and mood health. The top 5 subcategories of gummy supplements in the US are: vitamins/minerals, probiotics, botanical supplements, hair, skin & nails and women specialty.
“It’s exciting to be a part of a professional team that’s bringing something truly unique to the supplement marketplace,” said Toomey. “TopGum’s gummies can make a large impact on the way functional ingredients are made available to the consumer.”
